You are here

Article Text

Article menu

This article has a Reply. Please see:

Download PDFPDF
Correspondence
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic
  1. Pedro Santos-Moreno1,
  2. Josefina Chavez-Chavez2,
  3. Sandra Milena Hernández-Zambrano3,
  4. Diana Patricia Rivera-Triana2,
  5. Ruth Alexandra Castiblanco-Montañez3,
  6. Anggie Aza1,
  7. Diana Buitrago-Garcia4,
  8. Laura Villarreal1,
  9. Adriana Rojas-Villarraga2
  1. 1 Rheumatology, Biomab IPS, Bogotá, Colombia
  2. 2 Research Department, Fundacion Universitaria de Ciencias de la Salud, Bogota, Cundinamarca, Colombia
  3. 3 Nurse Department, Fundacion Universitaria de Ciencias de la Salud, Bogota, Cundinamarca, Colombia
  4. 4 Epidemiology, Biomab IPS, Bogotá, Colombia
  1. Correspondence to Dr Pedro Santos-Moreno, Rheumatology, Biomab IPS, Bogotá 1386, Colombia; pedrosantosmoreno{at}hotmail.com

http://dx.doi.org/10.1136/annrheumdis-2020-218165

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We have read with interest the work of Bozzalla-Cassione et al 1 published recently in your journal regarding the implementation of a telemedicine programme for patients with lupus in northern Italy. It is logical to suppose that the risk of patients with rheumatic diseases of having a more severe clinical course if they become infected with the COVID-19 infection is very high; however, although some of the reports show that there seems to be a low incidence of COVID-19 infection in patients with rheumatic disease, collaborative work with large cohorts is needed, which could show us the real incidence of COVID-19 infection in these patients and what happens with the establishment of telemedicine programmes.2–6

    We show an experience in a specialised centre in Bogota, Colombia; currently, we have a cohort of 5597 patients with rheumatoid arthritis (RA) in exclusively ambulatory care. On 12 March 2020, in Colombia, the health emergency by COVID-19 was established and a week later the Ministry of Health ordered the outpatient care procedure for the population in isolation. From that moment on, …

    View Full Text

    Footnotes

    • Collaborators No other collaborator.

    • Contributors PS-M and AR-V: study concepts and design, manuscript preparation, manuscript editing and final approval of the article. JC-C and DPR-T: acquisition of data, provided critical revision of the article, analysis, and interpretation, manuscript editing and final approval of the article. SMH-Z and RAC-M: provided critical revision of the article, manuscript preparation, manuscript editing and final approval of the article. AA, DG-B and LV: acquisition of data, analysis and interpretation, manuscript editing and final approval of the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and public were not involved in this first phase of the study; in future, at the end of the observational study, we will involve the patient expectations, believes and experiences in the in-person consultation, telemedicine models in addition to the experiences of the healthcare workers seeing those patients through the qualitative analysis of the study.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles